Jennison Associates LLC Novartis Ag Transaction History

Jennison Associates LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 06, 2020	SELL	$80.93 - $91.1 $17.5 Million - $19.7 Million	-215,883 Closed	0 $0
Q1 2020 May 06, 2020	SELL	$70.67 - $99.01 $186 Million - $260 Million	-2,626,060 Reduced 92.4%	215,883 $17.8 Million
Q4 2019 Feb 07, 2020	BUY	$84.35 - $95.37 $212 Million - $240 Million	2,516,662 Added 773.69%	2,841,943 $269 Million
Q3 2019 Nov 08, 2019	BUY	$85.54 - $94.26 $27.8 Million - $30.7 Million	325,281 New	325,281 $28.3 Million

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.